Forgot Password

Please enter your email below.*
To create your new password, please enter your email address below.
We will send an email with instructions to reset your password.
*It must be the same email you used to register for your account


The therapeutic landscape for PCSK9 inhibitors is rapidly evolving; therefore, pharmacists require education on the safety and efficacy of PCSK9 inhibitors for the treatment of hyperlipidemia. This curriculum will assist pharmacists in optimizing hyperlipidemia care, as well as enable them to provide both prescribers and patients with pertinent safety and efficacy data about this class of drugs. Expanding the use of PCSK9 inhibitors is warranted to improve clinical outcomes in patients with hyperlipidemia, and the various activities in this series as well as the video vignettes will highlight key takeaways to use in practice.

CE Activity Curriculum


Additional Videos


Latest News

BMI, LDL Cholesterol Are Important Metrics in Assessing COVID-19 Risk

Learn More >

Week in Review: Study Shows Substance Use Disorders Possibly Linked to COVID-19

Learn More >

FDA Approves New Treatment for Transthyretin Amyloid Cardiomyopathy

Learn More >

Trending News Today: Young Women Have Low Awareness of Cardiovascular Risks

Learn More >

Study: Daily Aspirin Does Not Reduce Risk of Major Cardiovascular Events

Learn More >

ASCEND Trial: Aspirin Prevents Serious Vascular Events in Diabetes

Learn More >

Study: Daily Aspirin Did Not Reduce Risk of First Heart Attack, Stroke

Learn More >

Trending News Today: Smokers More Likely to Develop Atrial Fibrillation

Learn More >


This resource center is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Personalize the information you receive by selecting targeted content and special offers.